Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company

headquartered in Mumbai, India. Glenmark Pharmaceuticals was founded in 1977 by Gracias
Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. He named the
company after his two sons. The company initially sold its products in India, Russia, and Africa.
The company went public in India in 1999, and used some of the proceeds to build its first
research facility. Saldanha's son Glenn took over as CEO in 2001,having returned to India after
working at PricewaterhouseCoopers. By 2008 Glenmark was the fifth-biggest pharmaceutical
company in India.

Capital Structure: -
Ratios: -
Ratios Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Debt Equity 0.46 0.40 0.66 0.74 0.69

Dividend / 2.50 2.50 2.50 2.50 2.00

Share(Rs.)
Dividend Payout 2.05 3.26 3.91 4.55 3.93
Ratio(%)

Current Ratio 1.20 1.28 1.96 1.85 2.25

Return on Net 6.76 11.93 11.13 10.24 13.58

worth / Equity
Quick Ratio 0.90 1.00 1.66 1.50 1.85

Share Price: -
The share price of any stocks is volatile and keeps changing throughout the day owing
to different factors. Glenmark Pharma share price is ₹791.75 as of 6 Sep '23.

Returns:-
For the year ending March 2023 Glenmark Pharma has declared an equity dividend of
250.00% amounting to Rs 2.5 per share. At the current share price of Rs 754.85 this results in a
dividend yield of 0.33%. The company has a good dividend track report and has consistently
declared dividends for the last 5 years.